Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Urinary Bladder, Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Not applicableLooking for participantsNCT07379281
What this trial is testing

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Who this might be right for
Bladder Cancer
Qilu Hospital of Shandong University 254
Testing effectiveness (Phase 2)Study completedNCT03558087
What this trial is testing

Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing

Who this might be right for
Bladder Cancer
Matthew Galsky 76
Not applicableStudy completedNCT02203136
What this trial is testing

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 16
Not applicableWithdrawnNCT03238664
What this trial is testing

Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaTransitional Cell Carcinoma
University of Southern California
Not applicableNot Yet RecruitingNCT07749924
What this trial is testing

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)
Tianjin Medical University Second Hospital 670
Testing effectiveness (Phase 2)WithdrawnNCT02845050
What this trial is testing

Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)

Who this might be right for
Bladder Cancer
Ligartis GmbH
Not applicableWithdrawnNCT00084578
What this trial is testing

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Fox Chase Cancer Center
Not applicableUnknownNCT01198808
What this trial is testing

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

Who this might be right for
Bladder Cancer
Technical University of Munich 50
Testing effectiveness (Phase 2)Study completedNCT04496219
What this trial is testing

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma In SituRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8+3 more
Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02989584
What this trial is testing

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 54
Large-scale testing (Phase 3)Looking for participantsNCT06510374
What this trial is testing

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals 454
Testing effectiveness (Phase 2)Active Not RecruitingNCT02621151
What this trial is testing

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

Who this might be right for
Muscle-invasive Urothelial Cancer of the Bladder
NYU Langone Health 60
Large-scale testing (Phase 3)UnknownNCT02951078
What this trial is testing

Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 172
Testing effectiveness (Phase 2)Ended earlyNCT00516750
What this trial is testing

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

Who this might be right for
Bladder Cancer
Kyoto University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06388720
What this trial is testing

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Who this might be right for
Bladder Cancer
National Cancer Center, Korea 82
Not applicableStudy completedNCT05939856
What this trial is testing

Lymph Node Dissection Before or After Cystectomy

Who this might be right for
Bladder Cancer
Jagiellonian University 50
Not applicableStudy completedNCT02861196
What this trial is testing

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Next Page